<DOC>
	<DOCNO>NCT00149552</DOCNO>
	<brief_summary>Zinc deficiency prevalent HIV infect individual abuse drug . The purpose study determine zinc therapy prevent immune failure HIV infect individual abuse drug low plasma zinc level .</brief_summary>
	<brief_title>Zinc Therapy HIV Infected Individuals Who Abuse Drugs</brief_title>
	<detailed_description>Low level zinc associate increase risk HIV-related death opportunistic infection HIV infect individual . Drug user especially susceptible zinc deficiency . The purpose trial evaluate effectiveness zinc therapy prevent immune failure HIV infect individual abuse drug . This trial last 30 month . Participants randomly assign receive either zinc supplement placebo . Male participant receive 15 mg zinc female participant receive 12 mg zinc . Clinical laboratory study visit occur 3 6 month interval throughout study .</detailed_description>
	<mesh_term>HIV Infections</mesh_term>
	<mesh_term>Substance-Related Disorders</mesh_term>
	<mesh_term>Zinc</mesh_term>
	<criteria>HIV infect Drug User Blood zinc level great 0.35 mcg/mL less 0.75mcg/ml Currently participate another clinical trial Blood selenium level le 85 mcg/L Pregnant intend become pregnant</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2012</verification_date>
	<keyword>Treatment Naive</keyword>
	<keyword>Treatment Experienced</keyword>
</DOC>